Medtronic Cardiovascular
Clinical trials sponsored by Medtronic Cardiovascular, explained in plain language.
Cardiovascular device division of Medtronic.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
New heart valve device offers hope for patients too sick for surgery
Disease control Recruiting nowThis study tests a new device to replace the mitral valve in people with severe mitral regurgitation (a leaky heart valve) who cannot have standard surgery or a less invasive repair. About 1,056 participants will receive the device and be followed for safety and quality of life. …
Phase: NA • Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
New Non-Surgical heart valve could help thousands with leaky tricuspid
Disease control Recruiting nowThis study tests a new device, the Medtronic Intrepid™ TTVR System, to replace a leaky tricuspid heart valve without open-heart surgery. It is for people with severe symptoms despite medication. About 1,186 participants will be followed to see if the device reduces complications …
Phase: NA • Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New heart valve study aims to fix leaky valve without Open-Heart surgery
Disease control Recruiting nowThis study is tracking 80 people with severe pulmonary valve regurgitation (a leaky heart valve) who receive the Harmony Transcatheter Pulmonary Valve. The valve is placed through a catheter, avoiding open-heart surgery. Researchers will check if the valve works well and stays in…
Phase: NA • Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Which stent graft shrinks aneurysms best? new trial aims to find out.
Disease control Recruiting nowThis study compares two medical devices (Endurant and Excluder stent grafts) used to treat abdominal aortic aneurysms—a bulging blood vessel in the belly that can be life-threatening if it bursts. About 600 people with large aneurysms will be randomly assigned to get one of the t…
Phase: NA • Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New valve replacement offers hope for heart leak patients who can't have standard surgery
Disease control Recruiting nowThis study tests a new device (Intrepid TMVR) to replace the mitral valve in people with severe mitral regurgitation (leaky heart valve) who are not candidates for standard surgery or repair. About 400 participants will receive the device and be followed for safety and effectiven…
Phase: NA • Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Second chance: can a new valve fix a failing TAVR without open surgery?
Disease control Recruiting nowThis study is for people whose first TAVR heart valve is failing. Doctors will place a new TAVR valve inside the old one. The goal is to see if this 'redo' procedure is safe and works well. About 225 people will take part, and researchers will check how the valve performs at 30 d…
Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC